The Road to Commercial-Scale iPSC Cell Therapy

• August 19, 2026

Phoenix Children’s Joins First Controlled Clinical Trial of Genetic Therapy for Dravet Syndrome

The first controlled phase 3 trial of a genetic therapy for Dravet syndrome is now underway – with Phoenix Children's as one of 28 sites nationwide.

• by

• August 13, 2026

• 4 min

Impact of cognitive impairment on postoperative delirium and discharge disposition following knee arthroplasty: a Japanese nationwide propensity score–matched study

• by Yu Mori, Kunio Tarasawa, Hidetatsu Tanaka, Ryuichi Kanabuchi, Naoko Mori, Kiyohide Fushimi, Toshimi Aizawa, Kenji Fujimori

• August 14, 2026

International Consensus on the Evaluation and Management of : Results From a Modified Delphi Survey

Hypothalamic hamartomas (HH) are rare developmental brain lesions frequently associated with medically refractory epilepsy and complex neurobehavioral, cognitive and endocrine comorbidities.

• by

• August 14, 2026

• 2 min